聚桂醇联合平阳霉素治疗120例静脉畸形疗效观察

Clinical efficacy of lauromacrogol combined with pingyangmycin in the treatment of venous malformation:clinical analysis of 120 consecutive cases

目的：通过与平阳霉素局部注射治疗静脉畸形对比,观察聚桂醇联合平阳霉素局部注射治疗静脉畸形的临床效果。方法：选取口腔颌面-颈部静脉畸形患者120例,病变直径4.0~6.0 cm,随机分为实验组（60例）和对照组（60例）,实验组采用聚桂醇联合平阳霉素局部注射治疗,两者间隔2周交替使用;对照组仅使用平阳霉素进行局部注射治疗,间隔2周注射1次,观察治疗后病变缩小程度、局部颜色、质地、体位试验变化及不良反应。采用SPSS 11.5软件包对数据进行统计学分析。结果：根据国际疗效评价标准,第2、3、4、5次治疗后,实验组的治疗效果显著优于对照组（P〈0.05）;第1、6次治疗后实验组与对照组的治疗效果未见显著差异（P〉0.05）;实验组治疗有效的平均次数显著少于对照组（P〈0.05）。结论：聚桂醇联合平阳霉素治疗静脉畸形与单纯使用平阳霉素相比,可提高疗效、缩短疗程,无明显不良反应。

PURPOSE： To compare the clinical efficacy of pingyangmycin and lauromacrogol combined with pingyangmycin in the treatment of venous malformations （VMs）. METHODS： One hundred and twenty patients with VM were randomly divided into lauromaerogol combined with pingyangmyein injection group （experimental group） and pingyangmyein injection group （control group）. The appropriate interval between different injection sessions was 2 weeks. After different sessions, the changes of lesions （including size, color, texture） as well as the results of posture test and adverse effects were analyzed by using SPSSll.5 software package. RESULTS： According to the international evaluation criteria for VM, the efficacy of the experimental group was significantly better than the control group after 2-5 sessions （P〈 0.05）. However, after 1 and 6 sessions, there was no significant difference in the efficacy between the experimental group and the control group （P〉0.05）. In addition, the average sessions required in the experimental group were significantly less than those in the control group （P〈0.05）. CONCLUSIONS： Compared to the single use of pingyangmycin, lauromacrogol combined with pingyangmycin is more effective for the treatment of VM, with fewer sessions required and no adverse effects.